# Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative Nausea

> **NCT00445055** · PHASE4 · TERMINATED · sponsor: **University Hospital, Bordeaux** · enrollment: 71 (actual)

## Conditions studied

- Nausea
- Vomiting

## Interventions

- **DRUG:** Droperidol

## Key facts

- **NCT ID:** NCT00445055
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2011-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00445055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00445055, "Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative Nausea". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00445055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*